二级预防的研究组织的前提文件材料.ppt

STROKE: SECONDARY PREVENTION THE WHO PREMISE STUDYMARGARITA E. DíAZCENTRE FOR ACADEMIC MEDICAL RESEARCHMontevideo Uruguay;DEFINITION;PREVALENCE OF RECURRENT STROKE;WHO PREMISE Study of secondary prevention of stroke Causes of stroke and its established risk factors Non-modifiable and modifiable risk factors Results of the WHO PREMISE Study Prevalence of the most important risk factors Use of medication from the WHO PREMISE Study By socio-demographic characteristics According to risk factors By clinical characteristics Predictors for the use of medication Perspectives of pharmacological intervention Clinical trials with universal treatment Specific treatment according to diagnosis: isquemic/hemorrhaegic stroke Compliance;OBJECTIVES OF THE WHO PREMISE STUDY;CRUDE PREVALENCE OF STROKE IN THE PARTICIPATING COUNTRIES IN THE WHO-PREMISE STUDYn=10 855;WHO PREMISE Study of secondary prevention of stroke Causes of stroke and its established risk factors Non-modifiable and modifiable risk factors Results of the WHO PREMISE Study Prevalence of the most important risk factors Use of medication from the WHO PREMISE Study By socio-demographic characteristics According to risk factors By clinical characteristics Predictors for the use of medication Perspectives of pharmacological intervention Clinical trials with universal treatment Specific treatment according to diagnosis: isquemic/hemorrhaegic stroke Compliance;NON-MODIFIABLE RISKFACTORS FOR STROKE;RATES of MORTALITY for CEREBROVASCULAR DISEASE by age and sex group, Canada;;REPORTED HISTORY OF RISK FACTORS IN PERCENTAGES AMONG ALL CVD PATIENTS;CLUSTERING OF RISK FACTORS IN PERCENTAGES AMONG ALL CVD PATIENTS;LYFESTYLE CHANGES HAVE A MAJOR IMPACT ON SECONDARY PREVENTON;ANTIHYPERTENSIVE TREATMENT IS 5–10 TIMES MORE SUCCESSFUL IN ELDERLY PATIENTS THAN IN MIDDLE-AGED PATIENTS WITH MILD HYPERTENSION;WHO PREMISE Study of secondary prevention of stroke Causes of stroke and its established risk factors Non-modifiable and m